Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $13.884 million which beat the analyst consensus estimate of $13.175 million by 5.38 percent. This is a 22.08 percent increase over sales of $11.373 million the same period last year.